Summary - A new market study, titled “Vertical Farming - Global Market Outlook (2015-2022)”has been featured on WiseGuyReports.
According to Stratistics MRC, the Global Vertical Farming Market is estimated at $1.15 billion in 2015 and is poised to reach $6.31 billion by 2022, growing at a CAGR of 27.5%. Increasing inclination towards healthy food without pesticides, rising urban population and no weather related crop failures are the factors favoring the market growth. However, limited variety of crops, high initial investment and lack of technical insights are the restraining factors for vertical farming market. Rapidly increasing city population has made farm land inadequate for cultivation, so there is need for alternative farming techniques which acts as opportunity for vertical farming.
Based on functional device, lighting segment is likely to dominate the vertical farming market during the forecast period, due to the replacement of traditional lighting systems by energy-efficient LEDs. Many advantages associated with hydroponics such as recycling of water and reduced nutrition costs, is expected to exhibit considerable growth over the forecast period. Asia-Pacific region is projected to hold the largest share of global vertical farming market due to increasing demand for high quality food, rising urban population and government incentives in China, Singapore, and Japan.
Some of the key players in the global market include Aerofarms, Agrilution, American Hydroponics, Everlight Electronics, Farmedhere, Green Sense Farms, Hort Americas, Illumitex, Inc., Koninklijke Philips N.V, Moflo Aeroponics, Nihon Advanced Agri Corporation, Pacific Group, Philips Horticulture Lamps, Sky Green and Spread Co.
Functional Devices Covered:
- Climate Control
o Air Purification/Control
o Ventilation Fans
o Other Climate Controlers
- Hydroponics Components
o Meters & Solutions
o Pumps & Irrigation
o Water Filtration
o Other Hydroponics Components
- Lighting
o Grow Light Ballasts
o Grow Light Reflectors
o Grow Light
- Sensors
o Crop Sensor
o Co2 Sensor
o Nutrient Sensor
o Ph Sensor
o Other Sensors
Growth Mechanisms Covered:
- Hydroponics
- Aeroponics
- Other Growth Mechanisms
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 2035002763 (UK)
Global Suture Needle Market Research Report: Information by Shapes (Straight Shaped Needles, J Shape Needles, Compound Curve Shaped Needles and Half Curved), Types (Eyed Needles and Eyeless), End Users (Ambulatory Surgical Centers, Hospital, Clinics and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027Market Insights:Market Research Future (MRFR)’s study reveals that the Americas suture needles market is set to expand at a healthy CAGR of 6.5% during the forecast period.
The developments in the healthcare sector have motivated the medical device manufacturers to develop their product portfolios.
Additionally, an upsurge in the number of surgeries is predicted, which is projected to expedite the expansion of the suture needles market over the assessment period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/552The market looks attractive at present and is likely to flourish over the next couple of years.
Some of the factors responsible for catapulting the market on an upward trajectory include rising healthcare expenditure, increasing innovations in the healthcare sector, the large-scale prevalence of chronic diseases, and increasing count of health care service centers, among others.
However, the shift towards surgical staplers for suturing, especially in the super specialty healthcare centers, is a major factor expected to hold the growth of the suture needles market during the assessment period.Market Segmentation:By type of needle, the suture needles market has been segmented into round bodied needle, spatula needle, reverse cutting needle, blunt point needle, conventional cutting needle, tapercut needle, and others.By needle end type, the Americas suture needles market is segmented into eyed and eyeless.By end-user, the suture needles market has been segmented into hospital, clinics, ambulatory surgical centers and others.Regional Outlook:By region, the Americas suture needles market has been segmented into North America and South America.
The growth is attributable to the increase in the number of laparoscopic surgeries.Competitive Dashboard:Some of the key players profiled in this report are 3M (U.S.), TNI medical AG (Germany), Roboz Surgical Instrument Co. (U.S.), Ethicon US, LLC.
The veterinary software market to grow from USD 442 million in 2017 to USD 594 million by 2022, at a CAGR of 6.1% during the forecast periodThe major factors that are expected to be driving the veterinary software market are rising companion animal ownership and demand for pet insurance with growing animal health expenditure.
However, lack of government incentives for the adoption of veterinary software, reluctance of veterinarians towards adopting new technologies, and lack of awareness about veterinary software in the developing countries are restricting the growth of Veterinary Software Industry.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186264514By delivery model, the on-premise delivery model segment is expected to dominate the veterinary software market.On the basis of delivery model, the global veterinary software market is segmented into two broad categories—on-premise model, and web-based/cloud-based model.
The on-premise model segment is estimated to account for the largest share of the global veterinary software market in 2017.
The large share of this segment can be attributed to the advantages of the on-premise delivery model, such as the low risk of data breach, flexible connection bandwidth, and the availability of easy customization options.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=186264514By practice type, the exclusive small animal practices segment is expected to register the highest CAGR during the forecast period.On the basis of practice type, the veterinary software market is segmented into exclusive small animal practices, mixed animal practice, and exclusive large animal practices.
The exclusive small animal practices segment is expected to register the highest CAGR during the forecast period.
The high growth in this segment can be attributed to the increasing number of small pet owners and rising annual spending on pet care in developed countries.The North America Veterinary Software Industry is expected to grow at the highest CAGR during the forecast periodNorth America is expected to witness the highest growth from 2017 to 2022, owing to the growing demand for quality pet care.
Idiopathic Pulmonary Fibrosis (IPF) Treatment Market HighlightsIt is estimated that the global IPF treatment market is expected to register a CAGR of 12.3% during the forecast period of 2019 to 2025, with a market value of USD 2,237 million in 2018.IPF is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period.
The Idiopathic Pulmonary Fibrosis (IPF) Treatment Market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases.
However, the high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment market.The global IPF treatment market is currently dominated by numerous market players.
For instance, in September 2018, FibroGen, Inc. announced that the grant of Fast Track designation by US Food and Drug Administration (FDA) for the company’s anti-CTGF antibody, Pamrevlumab, for the treatment of patients with IPF.Idiopathic Pulmonary Fibrosis (IPF) Treatment Market SegmentationThe global IPF treatment market has been segmented based on treatment.The market, based on treatment, has been further divided into drug class, oxygen therapy, lung transplant, and others.
The drug class segment is likely to hold a major share in the market due to the increasing adoption of the drugs for the treatment of IPF and wider preferability.
The oxygen therapy segment is predicted to be the fastest growing due to the increasing inclination of medical professionals towards this therapy for the treatment of IPF.Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Key PlayersSome of the key players in the global IPF treatment market are Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La Roche AG, Fibrogen, Inc., Cipla, Merck & Co., Inc., Prometic Life Sciences Inc., and others.Browse Full Report Details @ https://www.marketresearchfuture.com/reports/idiopathic-pulmonary-fibrosis-treatment-market-8109Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Regional AnalysisThe market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The global accountable care solutions market is segmented on the basis of product and service, delivery mode, end users and regions.
Based on product and service, the global accountable care solutions market is segmented into healthcare provider solutions, healthcare payer solutions and services.
Accountable Care Solutions Market Growth Request Free PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229274233Expected to witness the highest growth in the next five years.
The growing need to improve the profitability of healthcare operations and government initiatives for eHealth implementation to improve the quality of care delivered to patients & curtail healthcare costs are the major drivers of market growth.
The services segment is further classified into support & maintenance services, implementation services, consulting services, training & education services.Furthermore, on the basis of end users, the market is classified into healthcare providers and healthcare payers.
The highest market share of North America and European regions is primarily attributed to the presence and expansion of major healthcare IT companies through acquisitions which has improved the accessibility of accountable care solutions products and services in this region.
